Opportunity Information: Apply for RFA DK 10 501
Apply for RFA DK 10 501
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Limited Competition for the Continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Mar 17, 2010 and posted on Mar 17, 2010.
- Applicants must submit their applications by Jun 30, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Only institutions that received an award under CRISP II are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, RFA DK 10 501, is a limited competition from the National Institutes of Health (NIH), specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), to support the continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP). It is designed to keep a long-running, prospective observational study in polycystic kidney disease (PKD) moving forward by supporting the same established network of clinical sites and the central coordinating center that already built, maintained, and can still access the CRISP participant cohort and its associated imaging and clinical data. Because CRISP is a specialized longitudinal study with a well characterized participant group, the announcement limits eligibility to the institutions that previously received an award under CRISP II, ensuring continuity of follow-up, consistent methods, and reliable access to prior study infrastructure and records.
The main scientific goal is straightforward: continue follow-up of the existing CRISP participants, who are described as highly motivated and well characterized, and preserve the value of the long-term dataset by extending observation over time. A second major goal is to maintain CRISP as a platform for informative ancillary studies, meaning add-on or companion projects that can leverage the established cohort, imaging protocols, and data systems to answer additional PKD-related questions without having to recreate an entire consortium from scratch. In practical terms, the opportunity is about sustaining the clinical and imaging pipeline, maintaining data quality and coordination across sites, and enabling new analyses and sub-studies that build on the original CRISP investment.
The award mechanism is an NIH cooperative agreement (U01). That matters because a U01 is typically used when the NIH expects to have substantial programmatic involvement during the project, such as participation in steering or oversight activities, coordination requirements across multiple sites, and close collaboration on scientific and operational decisions. This is consistent with a multi-center consortium that relies on standardized imaging and data management processes and needs strong coordination between clinical centers and a central Data Coordinating and Imaging Analysis Center (DCIAC).
Funding is planned at about $1.5 million total in Fiscal Year 2011 to support four awards in total: three participating clinical centers plus one DCIAC. The budget guidance states that an applicant may request up to $225,000 per year in direct costs, for a project period of up to five years. Cost sharing or matching is not required. The announcement lists the funding instrument as discretionary and categorizes the activity under health, with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
Eligibility is intentionally narrow. While the general applicant types referenced include public and state-controlled institutions of higher education and private institutions of higher education, the controlling eligibility restriction is that only institutions that received an award under CRISP II may apply. This aligns with the stated rationale for the limited competition: only the existing CRISP sites and the DCIAC are positioned to continue follow-up seamlessly because they retain access to the cohort, the prospective observational data, and the established operational infrastructure. For leadership, the opportunity allows any qualified individuals with the appropriate skills, knowledge, and resources to serve as Project Director/Principal Investigator (PD/PI), and it reiterates NIH-wide encouragement for individuals from underrepresented racial and ethnic groups and individuals with disabilities to apply.
Applications must follow the U01 format constraints, including a Research Strategy section limited to 12 pages total, with tables, graphs, figures, diagrams, and charts counted within that limit. Key dates included in the listing are a posted and creation date of March 17, 2010, with an original and current closing date of June 30, 2010, and an archive date of July 31, 2010. The full announcement is referenced through the NIH Grants Guide link, and the contact listed for access or linking issues is the NIH Office of Extramural Research (OER) webmaster.
Frequently Asked Questions (FAQs) - RFA DK 10 501 (CRISP Continuation)
What is the focus of funding opportunity RFA DK 10 501?
RFA DK 10 501 is a limited-competition NIH funding opportunity from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support the continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP), a long-running prospective observational study in polycystic kidney disease (PKD).
Which NIH institute is sponsoring this opportunity?
The opportunity is sponsored by the National Institutes of Health (NIH), specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
What is CRISP and why is it being continued?
CRISP is a specialized longitudinal (prospective observational) study in PKD with a well-characterized participant cohort and established imaging and clinical data. The purpose of this opportunity is to keep follow-up of existing CRISP participants going and preserve the scientific value of the long-term dataset by extending observation over time.
What are the main scientific goals of this funding opportunity?
The primary goal is to continue follow-up of the existing CRISP participants to extend the longitudinal dataset. A second major goal is to maintain CRISP as a platform for ancillary studies, meaning companion projects that can leverage the existing cohort, imaging protocols, and data systems to address additional PKD-related questions without rebuilding a new consortium.
What kind of studies does this opportunity support?
It supports continuation of a prospective observational study and the infrastructure required to sustain standardized clinical and imaging operations, maintain data quality across sites, and enable additional analyses and ancillary sub-studies that build on the existing CRISP investment.
What award mechanism is used for this opportunity?
The award mechanism is an NIH cooperative agreement (U01).
What does it mean that this is a U01 cooperative agreement?
A U01 is typically used when NIH expects substantial programmatic involvement in the project. For a multi-center consortium like CRISP, this can include participation in steering or oversight activities, coordination requirements across multiple sites, and close collaboration on scientific and operational decisions.
How many awards are expected under this opportunity?
Funding is planned to support four awards total: three participating clinical centers plus one Data Coordinating and Imaging Analysis Center (DCIAC).
What is the role of the Data Coordinating and Imaging Analysis Center (DCIAC)?
Based on the description, the DCIAC functions as the central coordinating center for data coordination and imaging analysis, supporting standardized processes and strong coordination across the consortium sites.
How much funding is available?
Planned funding is about $1.5 million total in Fiscal Year 2011 to support the four awards.
What is the maximum budget an applicant may request?
An applicant may request up to $225,000 per year in direct costs.
How long can the project period be?
The project period may be up to five years.
Is cost sharing or matching required?
No. Cost sharing or matching is not required.
Is this a discretionary grant?
Yes. The funding instrument is listed as discretionary.
What is the CFDA number for this opportunity?
The CFDA number is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
Who is eligible to apply?
Eligibility is intentionally narrow: only institutions that previously received an award under CRISP II may apply. While the announcement references public and state-controlled institutions of higher education and private institutions of higher education as general applicant types, the controlling restriction is prior CRISP II award status.
Why is eligibility limited to prior CRISP II awardee institutions?
The opportunity is structured as a limited competition to ensure continuity of follow-up, consistent methods, and reliable access to the existing CRISP participant cohort, imaging and clinical data, and established study infrastructure and records.
Can new institutions join the consortium under this funding opportunity?
Based on the stated eligibility restriction, new institutions that were not CRISP II awardees are not eligible to apply under this announcement.
Who can serve as Project Director/Principal Investigator (PD/PI)?
Any qualified individuals with the appropriate skills, knowledge, and resources may serve as PD/PI. The announcement also reiterates NIH-wide encouragement for individuals from underrepresented racial and ethnic groups and individuals with disabilities to apply.
What application format constraints are specified?
Applications must follow U01 format constraints, including a Research Strategy section limited to 12 pages total. Tables, graphs, figures, diagrams, and charts count within the 12-page limit.
When was this opportunity posted and when did it close?
The listing shows a posted and creation date of March 17, 2010. The original and current closing date is June 30, 2010. The archive date is July 31, 2010.
Where is the full announcement referenced?
The full announcement is referenced through the NIH Grants Guide link.
Who is listed as the contact for access or linking issues?
The contact listed for access or linking issues is the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: US Nuclear Regulatory Commission Research Conference Grant and Cooperative Agreement Program
Previous opportunity: ENVIRONMENTAL MONITORING RESEARCH SUPPORT RELATED TO QUAGGA MUSSELS IN LAKES MEAD MOHAVE
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 10 501
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 10 501) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ancillary Studies in Immunomodulation Clinical Trials (R01) Apply for RFA AI 10 014 Funding Number: RFA AI 10 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Limited Competition for the Continuation of the NIDDK Gastroparesis Consortium (U01) Apply for RFA DK 10 502 Funding Number: RFA DK 10 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| NIDDK Multi Center Clinical Study Implementation Planning Grants (U34) Apply for PAR 10 197 Funding Number: PAR 10 197 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Mouse Metabolic Phenotyping Centers Consortium (U24) Apply for RFA DK 10 006 Funding Number: RFA DK 10 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Coordinating and Bioinformatics Unit for the Mouse Metabolic Phenotyping Centers and the Diabetic Complications Consortium (U24) Apply for RFA DK 10 007 Funding Number: RFA DK 10 007 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| NIDDK Centers for Diabetes Translation Research (P30) Apply for RFA DK 10 009 Funding Number: RFA DK 10 009 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Planning Grants for Translating Chronic Kidney Disease (CKD) Research into Improved Clinical Outcomes (R34) Apply for RFA DK 10 011 Funding Number: RFA DK 10 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Type I Diabetes Impact Award (DP3) Apply for RFA DK 10 012 Funding Number: RFA DK 10 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Collaborative Studies on The Central Nervous System and Glycemia (R01) Apply for PAS 11 029 Funding Number: PAS 11 029 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Program Project Applications (P01) Apply for PAR 11 043 Funding Number: PAR 11 043 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Optimizing Recovery and Preservation of Endogenous Insulin Secretion in Individuals with Prediabetes or Recent Onset of Type 2 Diabetes (U01) Apply for RFA DK 10 013 Funding Number: RFA DK 10 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lifestyle Interventions in Overweight and Obese Pregnant Women Consortium Research Coordinating Unit (RCU) (U01) Apply for RFA DK 10 015 Funding Number: RFA DK 10 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| A GenitoUrinary Development Molecular Anatomy Project (GUDMAP) (U01) Apply for RFA DK 11 001 Funding Number: RFA DK 11 001 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $100,000 |
| Limited Competition for the Continuation of Teen Longitudinal Assessment of Bariatric Surgery (Teen LABS) (UM1) Apply for RFA DK 10 503 Funding Number: RFA DK 10 503 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Fostering the Development of Interdisciplinary Team Science for the Study of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) (R24) Apply for RFA DK 10 016 Funding Number: RFA DK 10 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $350,000 |
| NIDDK Consortium Interconnectivity Network Coordinating Unit (dkCOIN CU) U24 Apply for RFA DK 11 005 Funding Number: RFA DK 11 005 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12) Apply for RFA DK 11 006 Funding Number: RFA DK 11 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Phase IIB Grants for Brain and Behavior Tools (R44) Apply for PA 11 135 Funding Number: PA 11 135 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Silvio O Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 11 003 Funding Number: RFA DK 11 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| NIDDK Multi Center Clinical Study Cooperative Agreement (U01) Apply for PAR 11 157 Funding Number: PAR 11 157 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 10 501", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
